IN THE SUPREME COURT OF TEXAS
════════════
No. 04-1023
In re Allied Chemical
Corporation, et al.,
Relators
════════════════════════════════════════════════════
On Petition for Writ of Mandamus
Argued November
16, 2005
Justice Brister delivered the opinion of the Court, in
which Justice Hecht, Justice Medina, Justice
Green, and Justice
Willett joined.
Justice Hecht filed a concurring opinion.
Chief Justice Jefferson filed a dissenting opinion, in which
Justice O’Neill, Justice
Wainwright, and Justice
Johnson joined.
Justice Wainwright filed a
dissenting opinion.
Trial judges have broad discretion in scheduling discovery and trial, but that
discretion has never been unlimited. As we stated in 1847, trial courts may set
trials as they wish, but not so indiscriminately that the parties are “deprived
of any just defense, or that their rights would in any manner be jeopardized.”
Since 1847, new kinds of litigation have emerged that require new applications
of this rule. Eleven years ago in Able Supply Co. v. Moye, we held that in mass tort cases involving hundreds
of parties and complicated causation questions, a trial judge could not postpone
responses to basic discovery until shortly before trial. Finding that is precisely what has
occurred here, we again grant mandamus relief.
I. The Proceedings and Mootness
Roughly 1,900 plaintiffs sued 30 defendants in Hidalgo County, alleging exposure to chemical
fumes and leaks from several sites where pesticides were mixed or stored before
the sites were placed in receivership in 1967 and remediated in 1980. The plaintiffs identified no particular
incidents or products, instead alleging exposure to a “toxic soup” of emissions
in the air for many decades. As we recently noted, no such claim “has ever been
tried or appealed in Texas,” and thus “the tort is immature.”
Five years after filing, the trial court set the first trial for little more
than six months away. Despite our admonitions that trial courts should “proceed
with extreme caution” in setting consolidated trials in immature mass torts, the trial court consolidated five claims
for the initial trial. The five plaintiffs had little in common — ranging in age
from 29 to 74, residing in various directions from two different sites, alleging
exposure over different parts of seven decades, and suffering injuries from
asthma and arthritis to miscarriages and heart disease,
and in two cases damaged property. Shortly
after the trial court’s order, we issued In re Van Waters & Rogers,
Inc., reversing the same kind of order in the same kind of case in the same
county. The defendants brought the opinion to the
trial judge’s attention, but he changed nothing. Neither did the Thirteenth
Court of Appeals, where the defendants sought mandamus relief to no avail.
But when we granted a stay and requested full briefing, the plaintiffs
retreated, asking the trial court to (1) sever out the property claims, (2) drop
one plaintiff, and eventually (3) withdraw its consolidation order and proceed
to trial on just one plaintiff’s claims. The trial court granted these requests,
ordering that “the personal injury claims of Plaintiff Guadalupe Garza proceed
to trial.”
We disagree with the dissent that this last order renders these proceedings moot
for several reasons. First, in their petition for mandamus (as well as in the
trial court), the defendants complained of two things — that the trial court
erred in setting a consolidated trial “in contravention of In re Van Waters
& Rogers, Inc. and in the absence of an adequate response to the Able
Supply Interrogatory.” The trial court has withdrawn consolidation (the
Van Waters problem), but one plaintiff’s claims have still been ordered
to trial despite inadequate responses (the Able Supply problem). As the
relief requested by the defendants is a trial of one plaintiff’s claims held a
reasonable time after the Able Supply interrogatory is adequately
answered, a controversy still exists whether they
are entitled to that.
Second, the defendants argue that while the plaintiffs have moved for
deconsolidation in the face of this mandamus proceeding, even though they were
unwilling to do so in the face of Van Waters, they have refused to give
any assurance that they will not seek future consolidated trials inconsistent
with Van Waters. The situation that gives rise to this proceeding is thus
fully capable of repetition, and if review can be evaded by the modification of
orders pending mandamus proceedings, the defendants would be put to the repeated
expense of seeking review only to have it denied by last-minute changes in the
trial court’s orders. An appellate court’s jurisdiction cannot be manipulated in
this way.
Third, our order staying the docket control order here preserved the parties’
positions as they were at the time, not as they hustled to change them
thereafter. The plaintiffs apparently filed supplemental answers after the trial
setting — not the order but the trial date itself. The question before us is not
changed by knowing what experts the plaintiffs would have finally disclosed at
trial; that they would not do so any earlier is precisely the defendants’
complaint. And while the defendants certainly did challenge the adequacy of
those answers at oral argument (the first time the plaintiffs asserted them as
an excuse), the question before us is not their adequacy but their timeliness.
Finally, while we encourage parties to work out pretrial disputes so appellate
courts need never consider them, we cannot encourage parties to manipulate
pretrial discovery to evade appellate review. Pretrial cannot be conducted one
way when appellate courts are looking and another way when they are not. As
hundreds of similar claims remain in this case and the plaintiffs stoutly
maintain they had no duty to supplement their answers at all, the question
before us is not moot as it is capable of repetition in a manner that evades
review.
II. The Trial Setting and Able Supply
In Able Supply, more than 3,000 plaintiffs sued nearly 300 defendants for
toxic exposure. After 8 years, the plaintiffs still had not named anyone who
could connect their injuries to any defendant’s product. Instead, each plaintiff
responded in discovery that this basic and crucial element of their claims “has
not been determined at this time, but will be supplemented at a later date.” As
here, the plaintiffs asserted that the trial court had “broad discretion to
manage its own docket, and . . . has acted well within that discretion in
determining that no answers are required at the present time.” We disagreed, holding that the trial
court’s apparent indifference as to when such information might be disclosed was
a clear abuse of discretion with no adequate remedy by appeal.
The issue in this case is the same. The defendants made the same request
as in Able Supply, asking for medical experts who could connect the
plaintiffs’ diseases to the defendants’ products. Although five years had passed since
filing, the plaintiffs all responded either “not applicable” or that “none of
their treating physicians” could do so. But the interrogatory did not ask about
treating physicians, but any expert; as we noted in Merrell Dow
Pharmaceuticals, Inc. v. Havner, treating
physicians usually cannot make this kind of connection. By changing the defendants’ question,
the plaintiffs were able to respond with almost nothing.
The plaintiffs point out that their supplemental answers included a long list of
chemicals to which they were “potentially exposed,” and medical articles and
expert reports suggesting some of those chemicals were “capable of causing” or
“significantly contributed” to some of their diseases. But as this Court
explained in Havner, “[t]o raise a fact issue
on causation . . . a claimant must do more than simply introduce into evidence
epidemiological studies.” Evidence that a chemical can
cause a disease is no evidence that it probably caused the
plaintiff’s disease. And as Havner illustrated, an expert’s assurance that
a study establishes causation does not make it so. Claimants must have an expert
who can answer why a study is reliable, and how the plaintiff’s exposure is
similar to that of the study’s subjects. An expert must also exclude other causes
with reasonable certainty, a special problem here as the plaintiffs
allege exposure to so many different chemicals. By failing to list any expert
who could make this vital connection, the plaintiffs’ responses were, for all
practical purposes, just like those in Able Supply: “We’ll tell you
later.”
We recognize this evidence is hard to obtain, but courts cannot “embrace
inferences that good science would not draw.” Without it, no one can prepare for
trial. Accordingly, we have repeatedly granted mandamus in mass toxic tort cases
when plaintiffs have refused to produce basic information like this.
The plaintiffs point out that this case comes to us in a different posture than
Able Supply, in which the trial court had refused to compel discovery.
Here, although the defendants have moved to compel discovery several times, the
order they challenge merely sets the case for trial. But that does not make this
case different for two reasons.
First, unless we assume the interrogatory was answered in bad faith, there is
nothing more to compel. The discovery rules have been amended since Able
Supply, now requiring that “a party must make a complete response, based on
all information reasonably available to the responding party or its attorney at
the time the response is made.” Parties and attorneys certify this to be
true when they sign a discovery response; they can no longer simply choose to
delay disclosure until the last minute. Taking their responses at face value,
the plaintiffs here and their attorneys certified that no one could make
the causal connection they needed. Given the short time remaining before trial,
the defendants properly objected that this rendered the trial setting premature;
they did not have to spend the few remaining weeks begging for better answers.
Second, Able Supply addressed not just inadequate responses but
inadequate time for discovery. There, the trial court never barred
discovery completely, as the plaintiffs promised to give better answers 30 days
before trial. But we held that was not enough:
In a suit
of this massive nature, which includes disparate exposures to a multitude of
products, requiring defendants to wait until 30 days before trial to obtain
crucial and probative evidence of a causal connection between their products and
plaintiffs’ injuries is such a denial of their rights as to go to the heart of
the case.
Here, the
plaintiffs never promised better answers any earlier; to the contrary, they
claimed to have “fully and accurately” responded already.
Thus, the problem here is the same as that in Able Supply: too little
time between adequate responses and trial for the defendants to have a fair
chance to mount a defense. This problem can be addressed from either end: the
defendants in Able Supply sought to move discovery responses up; the
defendants here sought to move the trial setting back. Defendants are not
required to seek both. Instead, the trial court abused its discretion by doing
neither.
III. Mandamus and Appeal
Of course, we generally do not consider interlocutory complaints about trial
settings. But we generally do not review orders
refusing to compel discovery either. Yet we did so in Able Supply for
three reasons.
First, we have granted mandamus when a discovery order imposes a burden on one
party far out of proportion to any benefit to the other. Here, as in Able Supply, the
burden of making 30 defendants prepare in the dark for 1,900 claims is far out
of proportion to the benefit of giving the plaintiffs more time (after five
years) to decide who or what injured them. Filing thousands of claims like those
here requires only a reasonable inquiry and belief that they are not
groundless; recovering on them requires considerably
more. In the meantime, thousands of hours and millions of dollars may be
needlessly wasted if the claims can never be proved. Mandamus is appropriate in
such cases to avoid this “monumental waste of judicial resources.”
Second, we have granted mandamus when a denial of discovery goes to the heart of
a party’s case. There are many cases in which it is
perfectly reasonable to conduct discovery up until 30 days before trial. But in suits like this one, denying
discovery until then goes to the very heart of this case, as well as what our
justice system is supposed to be about.
Third, we have granted mandamus when a discovery order severely compromises a
party’s ability to present any case at all at trial. No trial was set in Able Supply,
but the plaintiffs’ intention to withhold responses until shortly before then
meant the defendants could not prepare a viable defense. Late disclosure may not
compromise a defendant when the complaint is minor or causation obvious; but the
connection between chemical fumes and cancer is quite different, as is a
bellwether trial that may affect thousands of others.
We cannot ignore the trial court’s order here without ignoring Able
Supply. If mandamus was proper there, it must be here too.
IV. Conclusion
Since Able Supply, we have intervened to compel discovery only in complex
mass tort cases like this one. Similarly, today’s holding is no
indication that we intend to intervene in more trial settings. There are good
reasons to schedule trial settings well in advance, and few reasons to postpone
doing so until discovery is fully complete. But trial settings, like discovery
orders, cannot be used to hold the parties hostage.
It has long been the rule in Texas that plaintiffs bear the burden of
pleading and proving how they were injured and by whom. They cannot simply file suit against
everyone in the vicinity and demand that the defendants prove otherwise.
Therefore, we direct the trial court to vacate its order setting any of the
plaintiffs’ claims for trial until the defendants have a reasonable opportunity
to prepare for trial after learning who will connect their products to
plaintiffs’ injuries. The writ will issue only if the trial court fails to
comply.
___________________________________
Scott Brister
Justice
OPINION
DELIVERED: June 15, 2007
Please state the name and address of each and every
doctor, physician, psychiatrist, psychologist, counselor, or other medical
practitioner who has attributed your alleged injury made the basis of this
lawsuit to exposure to the Defendants’ products or Defendants’ conduct,
including the dates of treatment or examination of each such doctor, physician,
or other medical practitioner, and the name or identity of the products to which
your alleged injury is attributed.